A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people …

…, T Strandberg, J Tuomilehto, H Soininen, M Kivipelto - The Lancet, 2015 - thelancet.com
Background Modifiable vascular and lifestyle-related risk factors have been associated with
dementia risk in observational studies. In the Finnish Geriatric Intervention Study to Prevent …

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

M Kivipelto, T Ngandu, L Fratiglioni… - Archives of …, 2005 - jamanetwork.com
Background Vascular risk factors play a role in the development of dementia, including
Alzheimer disease (AD). However, little is known about the effect of body mass index and …

Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease

M Kivipelto, F Mangialasche, T Ngandu - Nature Reviews Neurology, 2018 - nature.com
Research into dementia prevention is of paramount importance if the dementia epidemic is
to be halted. Observational studies have identified several potentially modifiable risk factors …

World‐Wide FINGERS Network: a global approach to risk reduction and prevention of dementia

M Kivipelto, F Mangialasche, HM Snyder… - Alzheimer's & …, 2020 - Wiley Online Library
Reducing the risk of dementia can halt the worldwide increase of affected people. The
multifactorial and heterogeneous nature of late‐onset dementia, including Alzheimer's disease (…

Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

B Winblad, K Palmer, M Kivipelto, V Jelic… - Journal of internal …, 2004 - Wiley Online Library
The First Key Symposium was held in Stockholm, Sweden, 2–5 September 2003. The aim
of the symposium was to integrate clinical and epidemiological perspectives on the topic of …

Defeating Alzheimer's disease and other dementias: a priority for European science and society

…, G Johansson, L Jönsson, M Kivipelto… - The Lancet …, 2016 - thelancet.com
Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …

Alzheimer's disease

P Scheltens, B De Strooper, M Kivipelto, H Holstege… - The Lancet, 2021 - thelancet.com
In this Seminar, we highlight the main developments in the field of Alzheimer's disease. The
most recent data indicate that, by 2050, the prevalence of dementia will double in Europe …

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

M Kivipelto, EL Helkala, MP Laakso, T Hänninen… - Bmj, 2001 - bmj.com
Objective: To examine the relation of midlife raised blood pressure and serum cholesterol
concentrations to Alzheimer's disease in later life. Design: Prospective, population based study…

Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria

…, AA Gouw, MO Habert, DM Holtzman, M Kivipelto… - Alzheimer's & …, 2016 - Elsevier
During the past decade, a conceptual shift occurred in the field of Alzheimer's disease (AD)
considering the disease as a continuum. Thanks to evolving biomarker research and …

Alzheimer's disease: clinical trials and drug development

…, A Solomon, B Winblad, P Mecocci, M Kivipelto - The Lancet …, 2010 - thelancet.com
Alzheimer's disease is the most common cause of dementia in elderly people. Research
into Alzheimer's disease therapy has been at least partly successful in terms of developing …